S&P Futures
4,295.00 -3.25 (-0.08%) Dow Futures
33,863.00 -10.00 (-0.03%) Nasdaq Futures
13,668.00 -13.25 (-0.10%) Russell 2000 Futures
2,023.10 -0.70 (-0.03%) Crude Oil
88.88 -0.53 (-0.59%) Gold
1,797.10 -1.00 (-0.06%)
Cardiff Oncology, Inc. (CRDF)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.0400 |
| Open | 3.0000 |
| Bid | 2.9800 x 1100 |
| Ask | 3.0700 x 1000 |
| Day's Range | 2.8700 - 3.0913 |
| 52 Week Range | 1.1300 - 8.5800 |
| Volume | |
| Avg. Volume | 960,962 |
| Market Cap | 126.73M |
| Beta (5Y Monthly) | 1.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6740 |
| Earnings Date | Feb 23, 2022 - Feb 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.67 |
- PR Newswire
Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced company highlights and financial results for the second quarter ended June 30, 2022.
- PR Newswire
Cardiff Oncology to Present at the William Blair Biotech Focus Conference 2022
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a fireside chat and one-on-one meetings at the William Blair Biotech Focus Conference 2022, which is taking place at The St. Regis New York on July 12 – 13, 2022.
- Simply Wall St.
Is Cardiff Oncology, Inc. (NASDAQ:CRDF) Popular Amongst Institutions?
A look at the shareholders of Cardiff Oncology, Inc. ( NASDAQ:CRDF ) can tell us which group is most powerful. Insiders...
